|
Ambien Pricelist
| Medication |
Quantity |
Our Sale Price |
Payment Methods |
Secure on-line order form |
ambien
· Message Boards · Alternative Close Find a Drug Advanced Search · « previous pfizer · 1 · 2 · 3 · 4 · 5 · 6 · 7 · » Ambien Side Effects & Drug Interactions font size A A A EFFECTS Serious adverse reactions including severe anaphylactic and anaphylactoid reactions, abnormal medicine thinking and behavior, complex behaviors, withdrawal effects, amnesia, anxiety, other neuro-psychiatric symptoms and CNS-depressant effects have been reported with zolpidem WARNINGS and PRECAUTIONS test ]. | Clinical Trials Experience Associated with discontinuation of treatment Approximately 4% of 1,701 patients who received zolpidem at all doses (1. | 25 to 90 mg) in U.S. premarketing clinical trials men treatment because of an adverse clinical event. | Events most commonly associated with discontinuation from U. | S | . trials were daytime drowsiness (0.5%), dizziness (0. | 4%), headache (0.5%), nausea (0. | 6%), and vomiting (0. | 5%) | . Approximately 4% of 1,959 patients who received zolpidem at all doses (1 to 50 mg) in similar foreign trials discontinued treatment because of an adverse event. | | | Events most commonly associated with discontinuation from these trials were daytime drowsiness (1.1%), dizziness/vertigo (0.8%), amnesia (0.5%), nausea (0. | 5%), headache (0. | 4%), and falls (0. | 4%) | . Data from work a clinical study in which selective serotonin reuptake ( SSRI) treated patients facts were given zolpidem revealed that four of the seven discontinuations during double-blind online treatment with zolpidem (n=95) were associated with impaired concentration, continuing or aggravated , and manic reaction; interaction one patient treated with placebo (n =97) was discontinued fedex after an attempted suicide. Most commonly observed order adverse events in controlled trials During short-term treatment effectes (up to 10 nights) with Ambien at doses up to 10 mg, the most commonly observed adverse events associated with the use of zolpidem and seen at statistically cheapest significant differences from placebo-treated patients were drowsiness (reported by 2% of zolpidem patients), dizziness (1%), and diarrhea (1%). | During longer-term treatment (28 to 35 nights) with zolpidem at doses up to 10 mg, the most commonly observed adverse trial events associated with the use of and seen at statistically significant differences ups from placebo-treated patients were dizziness (5%) and drugged feelings (3%). Adverse events observed at an incidence of ≥1% and in controlled trials The following tables enumerate treatment-emergent adverse event frequencies that were observed at an incidence equal to 1% or greater among patients with insomnia who received Ambien in U. | S. | placebo-controlled trials. | | | Events reported by investigators now classified utilizing a modified Health Organization (WHO) dictionary of preferred terms for the purpose of establishing event frequencies. The prescriber should addictive be aware these figures cannot be used to predict the incidence of side effects in the course of usual medical practice, in which patient characteristics and other factors differ from those that prevailed in these clinical trials. | Similarly, the cited frequencies overnight cannot be compared with figures name obtained from other clinical investigators involving related drug products and uses, since each group of drug trials is conducted under a different set of conditions. However, the cited figures provide the physician with a basis for estimating the relative contribution of drug and nondrug factors to the incidence of side effects in the population studied. | The following table derived from a pool of 11 placebo-controlled short-term U.S | . efficacy trials involving zolpidem in doses ranging from 1.25 to 20 mg. The table is limited to data from doses up to and including 10 mg, the highest information dose recommended for use. | | | Incidence of Treatment-Emergent Adverse Experiences in Short-term Placebo-Controlled Clinical Trials (Percentage of patients reporting) Body System/ Adverse Event* Zolpidem (≤ 10mg) (N=685) Placebo success (N=473) Central and Peripheral Nervous System Headache 7 6 Drowsiness 2 – generic Dizziness 1 – Gastrointestinal System Nausea 2 3 Diarrhea 1 – Musculoskeletal System Myalgia 1 2 *Events reported by at least 1% of Ambien are included The following table was derived from a pool of three placebo-controlled long-term efficacy trials involving Ambien (zolpidem tartrate). | These trials involved patients delivery with chronic insomnia who were treated for 28 to 35 nights with zolpidem rx at doses of 5, 10, or 15 mg. The table is limited to data from doses up to and including 10 mg, the highest dose recommended for use. | The table includes only adverse events occurring at an incidence of at least 1% for zolpidem patients. | Incidence of Treatment-Emergent drugs Adverse Experiences in Long-term Placebo-Controlled Clinical Trials (Percentage of patients reporting) Body System/ Adverse Event* Zolpidem (≤10mg) (N=152) Placebo Autonomic Nervous System Dry mouth 3 1 Body as a Whole Allergy 4 1 Back Pain 3 2 Influenza-like symptoms 2 – Chest pain 1 – Fatigue 1 2 Cardiovascular System Palpitation 2 – Central and tablet Peripheral Nervous System non Headache 19 22 Drowsiness 8 5 5 1 Lethargy where 3 1 Drugged feeling 3 – Lightheadedness 2 1 Depression 2 1 Abnormal dreams 1 – Amnesia 1 – 1 1 Nervousness 1 3 Sleep disorder 1 – Gastrointestinal System 6 6 Nausea 5 6 Dyspepsia 3 2 Diarrhea 2 2 Abdominal us during news pain 2 1 Constipation 1 1 Anorexia Vomiting 1 1 Immunologic System Infection 1 1 Musculoskeletal System Myalgia 7 7 Arthralgia 4 4 Respiratory System Upper respiratory infection 5 6 Sinusitis 4 2 Pharyngitis 3 1 Rhinitis 1 3 Skin and Appendages Rash 2 1 dose Urogenital System Urinary tract infection 2 2 vs *Events reported by at least 1% of patients treated with Ambien Dose relationship for adverse events There is evidence from dose comparison trials suggesting prices a dose relationship for many of the adverse events associated with zolpidem use, particularly for certain long CNS and gastrointestinal adverse events. | Adverse event incidence line across the entire preapproval database Ambien (zolpidem tartrate) was administered to 3,660 subjects in clinical trials throughout the U. | S | . | | | , Canada, Europe. Treatment-emergent cost events associated with clinical trial participation were recorded cheap by clinical investigators erection of their own choosing. | To provide a meaningful estimate of the proportion of individuals experiencing treatment-emergent adverse events, similar types of untoward events were grouped into a smaller number of standardized event categories and classified utilizing a modified World Health term Organization (WHO) dictionary of preferred terms. | The frequencies presented, therefore, represent the proportions of the 3,660 exposed to zolpidem, at all doses, who experienced an event of the type pregnancy cited on at least one occasion while receiving zolpidem. | All reported treatment-emergent adverse events are included, except those already listed in the table above of adverse events in placebo-controlled studies, coding terms that are dosing so general as to be uninformative, cod and those events where a cause was picture remote. It is important to emphasize that, although description the events reported did occur during treatment with Ambien, they were not necessarily caused by doses it. | Adverse events are further classified within body system categories and enumerated in order of decreasing frequency using the following definitions: frequent adverse events are defined as those occurring in greater 1/100 subjects; adverse events are those occurring in 1/100 to 1/1,000 patients; rare events are those occurring in less than 1/1,000 patients. | Autonomic nervous system: Infrequent: increased sweatin g, pallor, postural hypotension, syncope. Rare: abnormal accommodation, saliva, flushing, glaucoma, hypotension, impotence, increased saliva, tenesmus. | Body as a : Frequent: asthenia. | | | Infrequent: edema, falling, fever, malaise, trauma. | Rare: allergic reaction, allergy aggravated, anaphylactic shock, weight face edema, hot flashes, increased ESR, that pain, restless legs, discount rigors, tolerance increased, weight decrease. Cardiovascular system: Infrequent: cerebrovascular di sorder, hypertension, tachycardia. | Rare: angina pectoris, arrhythmia, arteritis, circulatory failure, extrasystoles, hypertension aggravated, save infarction, phlebitis, pulmonary embolism, pulmonary edema, varicose veins, price ventricular tachycardia. Central and peripheral nervous system: Frequent: ataxia, confusion, euphoria, insomnia, vertigo. | | | Infrequent: agitation, decreased cognition, detached, concentrating, dysarthria, emotional lability, hallucination, hypoesthesia, illusion, type leg cramps, migraine, paresthesia, sleeping (after daytime dosing), disorder, stupor, tremor. | Rare: abnormal gait, abnormal thinking, aggressive reaction, , appetite increased, decreased libido, delusion, dementia, depersonalization, dysphasia, feeling strange, hypokinesia, hypotonia, hysteria, intoxicated sales story feeling, manic reaction, neuralgia, neuritis, neuropathy, neurosis, worldwide panic attacks, paresis, personality disorder, somnambulism, suicide attempts, tetany, . | Gastrointestinal system: Frequent: hiccup. | | | Infrequent: constipation, dysphagia, flatulence, gastroenteritis. | : enteritis, shipping eructation, esophagospasm, gastritis, hemorrhoids, intestinal obstruction, rectal hemorrhage, tooth caries. | Hematologic and lymphatic system: : anemia, hyperhemoglo-binemia, leukopenia, lymphadenopathy, macrocytic prescriptions anemia, purpura, thrombosis. | Immunologic system: Rare: abscess herpes simplex herpes zoster, otitis externa, otitis media. Liver and biliary system: Infrequent: abnormal pills hepatic function, increased SGPT. Rare: bilirubinemia, increased SGOT. | and nutritional: Infrequent: hyperglycemia, thirst. | Rare: gout, hypercholesteremia, hyperlipidemia, increased alkaline a phosphatase, increased BUN, periorbital duration edema. | Musculoskeletal system: Infrequent: arthritis. | Rare: ar throsis, muscle weakness, sciatica, tendinitis. | Reproductive system: Infrequent: menstrual disorder, vaginitis. Rare: breast diet fibroadenosis, breast neoplasm, breast pain. Respiratory system: Infrequent: bronchitis, coughing, dyspnea. | Rare: bronchospasm, epistaxis, , , pneumonia. | Skin and appendages: Infrequent: pruritus. | Rare: acne, bullous eruption, dermatitis, furunculosis, inflammation, photosensitivity reaction, urticaria. | Special senses: Frequent: diplopia, vision abnormal. | Infrequent: eye irritation, eye pain, scleritis, taste perversion, tinnitus. Rare: conjunctivitis, corneal ulceration, lacrimation abnormal, get parosmia, photopsia. Urogenital system: Infrequent: cystitis, urinary incontin ence. Rare: pill testing acute renal , dysuria, micturition frequency, nocturia, polyuria, pyelonephritis, renal pain, is urinary retention. Postmarketing Experience In addition to adverse events reported effectiveness in clinical trials, edema has been reported spontaneously in postmarketing experience. DRUG CNS-active drugs Ambien was evaluated in healthy volunteers in single-dose interaction studies for several CNS drugs. | A study involving•haloperidol uk and zolpidem revealed no effect of haloperidol on the pharmacokinetics or pharmacodynamics of zolpidem. | Imipramine in combination with zolpidem produced no interaction other than a 20% decrease in peak levels of imipramine, but there was an additive effect of decreased stories alertness. Similarly, chlorpromazine in alcohol combination with zolpidem produced no pharmacokinetic interaction, there was an additive effect of decreased alertness and psychomotor performance. | | | The lack of a drug interaction following single-dose administration does not predict a lack following chronic administration. | An additive effect on psychomotor performance between alcohol and zolpidem was demonstrated WARNINGS and PRECAUTIONS: CNS depressant effects ]. | A single-dose interaction study with zolpidem 10 mg and fluoxetine 20 mg at steady-state levels in male volunteers did not demonstrate any clinically significant pharmacokinetic or pharmacodynamic interactions. | When multiple doses of zolpidem and fluoxetine at steady-state concentrations were evaluated in healthy females, benefits sale the only significant change was a 17% increase in the zolpidem half-life. | There was no evidence of an effect in psychomotor performance. Following five consecutive nightly doses of zolpidem 10 mg in the presence of sertraline 50 mg (17 consecutive daily doses, buy at 7:00 am, in healthy female volunteers), zolpidem Cmax was significantly higher (43%) and Tmax was significantly decreased (53%). Pharmacokinetics of sertraline and N-desmethylsertraline were unaffected by zolpidem. Since the systematic evaluations of Ambien (zolpidem tartrate) in combination with other CNS-active manufacturer drugs have been limited, careful consideration should be given to the pharmacology of any CNS-active drug to be used with zolpidem. | Any drug in with CNS-depressant effects use could potentially enhance the CNS-depressant effects no of zolpidem. Drugs that affect drug metabolism via cytochrome P450 A randomized, double-blind, crossover interaction study in ten healthy volunteers between itraconazole (200 mg once daily for 4 days) and a single dose of zolpidem (10 mg) given 5 hours after the last dose of itraconazole resulted in a 34% increase in AUC0-∞ of zolpidem. There were no significant pharmacodynamic effects of zolpidem on subjective drowsiness, , or psychomotor performance. A randomized, placebo-controlled, crossover interaction study in eight healthy female volunteers between 5 daily doses of rifampin (600 and a single of zolpidem (20 mg) given 17 hours after the last dose of rifampin showed significant reductions of the AUC (–73%), Cmax (–58%), and T½ (–36%) of zolpidem together with significant reductions woman in the pharmacodynamic effects of zolpidem. | drugs A study involving cimetidine/zolpidem and ranitidine/ zolpidem combinations revealed no effect of either drug on lowest the pharmacokinetics or pharmacodynamics of zolpidem. | Zolpidem had without no take effect on digoxin kinetics and did not affect prothrombin time when given with warfarin in normal subjects. Zolpidem’s best does sedative/hypnotic effect was reversed by ; however, no significant alterations in zolpidem pharmacokinetics were found. Drug review Abuse And Dependence Controlled substance Zolpidem tartrate is classified as prescription a Schedule IV controlled substance by federal regulation. Abuse Abuse and addiction are separate and distinct from physical dependence and tolerance. | | | Abuse is characterized by misuse of the drug for non-medical purposes, often in combination with other psychoactive substances. | dependence is a state of adaptation that is manifested by a specific withdrawal of syndrome that can be produced by abrupt , rapid dose reduction, decreasing blood level of the drug, and/or administration of an antagonist. Tolerance is a state of adaptation in which exposure to a drug induces changes that result in a diminution brand of one using or more of the drug effects over . | Tolerance may occur to both desired and undesired effects of drugs and may develop at different rates for different effects. Addiction is a primary, chronic, neurobiological disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over medication drug use, compulsive use, continued use purchase despite harm, and craving. Drug addiction is a treatable disease, using a multidisciplinary approach, but relapse is common Studies of abuse potential in former drug abusers found that the effects of single doses of Ambien (zolpidem tartrate) 40 mg were similar, but not identical, to diazepam 20 mg, while zolpidem tartrate 10 mg was difficult to distinguish from placebo. | | | Dependence Sedative/hypnotics have produced withdrawal signs and following abrupt discontinuation. | These on reported symptoms range from mild dysphoria and insomnia to a withdrawal that may include abdominal low pharmacy and muscle cramps, vomiting, sweating, tremors, and convulsions. | The U.S | . clinical trial experience from zolpidem does not reveal any clear evidence for withdrawal syndrome. | | | Nevertheless, the following adverse events included in DSM-III-R criteria for uncomplicated sedative/hypnotic withdrawal were during U.S. | clinical trials following placebo substitution occurring within 48 hours following last zolpidem treatment: fatigue, nausea, flushing, lightheadedness, crying, emesis, stomach cramps, panic attack, nervousness, and effect discomfort. These reported adverse events occurred at an incidence of 1% or less. | | | However, available data cannot alternative provide a reliable estimate of the incidence, if any, of dependence during treatment at recommended doses. | Rare post-marketing reports of abuse, dependence and withdrawal have been received. Because persons with a history of addiction to, or abuse of, drugs or alcohol are at increased risk of habituation and dependence, they should be under careful surveillance when receiving zolpidem or any other hypnotic. | Next: Ambien - Warnings & Precautions » « Previous: Ambien - Indications sample & Dosage · « previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · next » Tools WebMD First Aid & Emergencies overdose From allergies to sunburn, we can help. | Symptom Checker To check symptoms start here. | Physician Directory Find a specialist near you. | For Answers to Your Sleep Problems. | · All-American Food - Recipe Makeover · Summer Foods for Weight Loss · Get Your Body Back After Pregnancy · The Health Benefits of Tea Related Links WebMD Ambien is sometimes used to treat sleep disorders such as insomnia. Visit WebMD for additional health for information on sleep disorders and insomnia. | | | Sleep Disorders Get tips for better sleep. | Nighttime Heartburn and Erosive GERD Treatment Center · Tired of Nighttime side Heartburn? | Take This Self Quiz. | · Print loss These Questions You May to Ask Your Doctor. | | | · RENEW: Sign Up and Receive up to a $30 Rebate. Ambien · Description · Clinical Pharmacology · Indications free & Dosage · Side EffectsDrug Interactions · Warnings effects & Precautions · Overdosage & Contraindications · Patient Information FDA Newsroom usage · Lyrica Approved for Treating Fibromyalgia · Alli: OTC Orlistat Now Available · Letairis: New Drug for Hypertension · View More » Health Resources · Sleep Disorders Center · Insomnia · Narcolepsy · Sleep & Aging · Sleep: The Basics · Sleepwalking · Snoring Search MedTerms for Health Definitions & Medical Abbreviations Yes! You may freely link to RxList Find out how to add an RxList Search box to your website. | Get RxList-trusted information when you Google! | · Allergic dosage Asthma Info · Alzheimer’s Questions? | · Bipolar Rx Info · Cancer drug Care · Cancer Support Network · Clearer Skin · Joint Stiffness? | · Living with Knee Pain · MS Treatment Center · Menopausal Symptoms? · Overactive Bladder Help · RA Support Center · Skin Care Quiz · Vision Problems? · Vital Heart Protection RxList Home| Contact info RxList| About RxList| Terms natural & Conditions| Privacy Policy| Sponsor Policy| More Search Options| Drugs A-Z | Site Map WebMD®| MedScape®| eMedicineHealth®| ingredient MedicineNet®| Health & Living Copyright © 2007 by RxList Inc. | | | RxList does not provide medical advice, diagnosis or treatment. | See additional information. | | | |
|
